Literature DB >> 2646195

Polymorphonuclear cell count response and duration of antibiotic therapy in spontaneous bacterial peritonitis.

T L Fong1, E A Akriviadis, B A Runyon, T B Reynolds.   

Abstract

The purposes of this study were (a) to measure serially ascitic fluid polymorphonuclear cell response in treated spontaneous bacterial peritonitis and (b) to determine whether an ascitic fluid polymorphonuclear cell count of less than 250 per mm3 on serial paracenteses was a satisfactory endpoint for antibiotic therapy. Thirty of 33 patients showed an exponential fall in ascitic fluid polymorphonuclear cell count after 48 hr of antibiotic therapy; the magnitude of decrease correlated with survival (p less than 0.01). Among the patients whose antibiotic therapy was discontinued when the ascitic fluid polymorphonuclear cell count reached 250 per mm3 or less, the duration of therapy was considerably shorter than for the patients who received "conventional" therapy (p less than 0.01). Recurrence of spontaneous bacterial peritonitis was similar in the two groups. Mortality correlated with the severity of underlying liver disease but not with duration of antibiotic therapy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2646195     DOI: 10.1002/hep.1840090313

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  18 in total

Review 1.  Evidence based case report. Antibiotic treatment for spontaneous bacterial peritonitis.

Authors:  K Soares-Weiser; M Paul; M Brezis; L Leibovici
Journal:  BMJ       Date:  2002-01-12

2.  Spontaneous Bacterial Peritonitis.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-12

3.  IL-6 and TNF alpha in ascitic fluid during spontaneous bacterial peritonitis.

Authors:  J Deviere; J Content; A Crusiaux; E Dupont
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

4.  Granulocyte elastase in cirrhotic patients with spontaneous bacterial peritonitis.

Authors:  F Casafont; M Rivero; M D Fernandez; J Crespo; E Fabrega; E Sánchez; F Pons-Romero
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

5.  Short-course ceftriaxone therapy in spontaneous bacterial peritonitis.

Authors:  G Javid; B A Khan; B A Khan; A H Shah; G M Gulzar; M A Khan
Journal:  Postgrad Med J       Date:  1998-10       Impact factor: 2.401

6.  Ascites.

Authors:  Nelson Garcia; Arun J. Sanyal
Journal:  Curr Treat Options Gastroenterol       Date:  2001-12

7.  Persistent spontaneous bacterial peritonitis: a common complication in patients with spontaneous bacterial peritonitis and a high score in the model for end-stage liver disease.

Authors:  Archita P Desai; Nancy Reau; K Gautham Reddy; Helen S Te; Smruti Mohanty; Rohit Satoskar; Amanda Devoss; Donald Jensen
Journal:  Therap Adv Gastroenterol       Date:  2012-09       Impact factor: 4.409

8.  Spontaneous bacterial peritonitis: Analysis of treatment and outcome.

Authors:  G H Victor; S M Opal
Journal:  Can J Infect Dis       Date:  1991

Review 9.  [Spontaneous bacterial peritonitis].

Authors:  J Zundler; J C Bode
Journal:  Med Klin (Munich)       Date:  1998-10-15

10.  Analysis of clinical course and prognosis of culture-positive spontaneous bacterial peritonitis and neutrocytic ascites. Evidence of the same disease.

Authors:  R Terg; D Levi; P Lopez; C Rafaelli; S Rojter; R Abecasis; F Villamil; H Aziz; A Podesta
Journal:  Dig Dis Sci       Date:  1992-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.